Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-17
2011-05-17
Richter, Johann R (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S015000, C546S016000
Reexamination Certificate
active
07943630
ABSTRACT:
This invention relates to novel 3,9-diaza-spiro[5.5]undecane derivatives useful as monoamine neurotransmitter re-uptake inhibitors.In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
REFERENCES:
patent: 4041174 (1977-08-01), Sapse
patent: 6288079 (2001-09-01), Scheel-Kruger et al.
patent: WO-97/16451 (1997-05-01), None
M. S. Smyth et al, Bioorganic & Medicinal Chemistry Letters Nov. 2001, 1289-1292.
Eriksen Birgitte L.
Nielsen Elsebet Ostergaard
Peters Dan
Redrobe John Paul
Birch & Stewart Kolasch & Birch, LLP
Jean-Louis Samira
NeuroSearch A/S
Richter Johann R
LandOfFree
3,9-diaza-spiro[5.5]undecane derivatives and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,9-diaza-spiro[5.5]undecane derivatives and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,9-diaza-spiro[5.5]undecane derivatives and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702757